Related Experiment Video
Updated: Aug 15, 2026
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Urinary C5a as a Noninvasive Marker of Renal Activity, Histopathological Severity, and Outcomes in ANCA-Associated
Kenta Fujimoto1, Masao Kikuchi1, Atsushi Goan1
1Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Insights
Urinary C5a/Cr levels indicate kidney damage severity in ANCA-associated vasculitis (AAV). Higher levels correlate with worse kidney outcomes and more severe kidney disease, aiding in risk stratification.
Area of Science:
- Nephrology
- Immunology
- Complement System
Background:
- Complement activation is crucial in ANCA-associated vasculitis (AAV) pathogenesis.
- The clinical significance of urinary complement fragments in AAV remains largely unknown.
- This study explores the link between urinary complement fragments and renal outcomes in AAV patients.
Purpose of the Study:
- To determine if urinary complement fragments (C3a, C5a, C5b-9) reflect renal injury severity in AAV.
- To assess the association of these fragments with renal outcomes in AAV patients.
- To explore the utility of urinary complement-eGFR classifications for risk stratification.
Main Methods:
- Retrospective analysis of 57 AAV patients with renal involvement.
- Measurement of urinary C3a, C5a, and C5b-9 normalized to creatinine (U-C3a/Cr, U-C5a/Cr, U-C5b-9/Cr) at diagnosis/relapse.
- Primary outcome: End-stage kidney disease (ESKD) or all-cause mortality; secondary outcomes: eGFR changes, histopathology.
Main Results:
- High U-C3a/Cr and U-C5a/Cr were linked to significantly lower event-free survival.
- Higher U-C5a/Cr correlated with less eGFR improvement and more severe kidney histopathology.
- Combined U-C5a/Cr and eGFR classifications showed distinct risk categories.
Conclusions:
- Urinary C5a/Cr is associated with poorer renal outcomes and increased kidney disease severity in AAV.
- U-C5a/Cr consistently reflects intrarenal disease severity compared to U-C3a/Cr.
- Urinary complement-eGFR classifications offer potential for noninvasive renal risk stratification in AAV.
Background:
Complement activation plays a central role in the pathogenesis of ANCA-associated vasculitis (AAV). However, the clinical implications of urinary complement fragments remain unclear. We investigated whether urinary complement fragments reflect the severity of renal injury and whether they are associated with renal outcomes in patients with AAV.
Methods:
We retrospectively analyzed 57 patients with AAV and renal involvement. Urinary complement C3a, C5a, and C5b-9 levels were measured at diagnosis or relapse and normalized to urinary creatinine (U-C3a/Cr, U-C5a/Cr, and U-C5b-9/Cr). The primary outcome was a composite of ESKD requiring chronic dialysis or all-cause mortality. Secondary analyses evaluated longitudinal changes in eGFR and myeloperoxidase-ANCA titers, and associations with renal histopathological findings at diagnosis.
Results:
Over a median follow-up of 21.5 months, 14 patients reached the primary outcome. Event-free survival was significantly lower in the high U-C3a/Cr and U-C5a/Cr groups than in the corresponding low groups. High baseline U-C3a/Cr and U-C5a/Cr were associated with 3.86-fold and 3.73-fold higher unadjusted risks of the primary composite outcome, respectively. However, the U-C5a/Cr ratio showed a broader association with renal disease severity. Higher U-C5a/Cr ratios were associated with less improvement in eGFR during follow-up and with several histopathological abnormalities, including a higher proportion of cellular crescents, lower proportion of normal glomeruli, and more severe tubulointerstitial lesions. Exploratory analyses combining urinary complement markers with baseline eGFR demonstrated progressive separation of renal risk categories, particularly for the U-C5a/Cr-eGFR classification.
Conclusions:
U-C5a/Cr was associated with renal outcomes, impaired renal functional recovery, and histopathological severity of AAV. Although U-C3a/Cr and U-C5a/Cr showed prognostic associations, U-C5a/Cr reflected intrarenal disease severity more consistently. Exploratory urinary complement-eGFR classifications may provide complementary noninvasive information for renal risk stratification in AAV. Further prospective multicenter studies are required to validate these findings.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:29Acute Kidney Injury II: Pathophysiology